Navigation Links
CU Cancer Center study: Young patients with metastatic colorectal cancer at higher risk
Date:9/30/2013

risk changes as people age, rather than simply comparing one group (patients younger than 40) with another group (patients older than 40)," Lieu said.

Previous studies in this field have split the population into two mutually exclusive groups, establishing rigid limits between those patients younger than 40 or 50 and those older than that age. The new research, however, did not use such a cut-off approach and includes data spanning all ages.

"The reason we did this is we believe a 49-year-old patient with colorectal cancer may be different than a 20-year-old. By including them in the same group of people younger than 50 years old, we might be mistakenly considering them the same," said Lieu.

Lieu and his colleagues analyzed information from a database of clinical trials in advanced colorectal cancer supported by the French "Aide et Recherche en Cancrologie Digestive" Foundation (ARCAD), which includes the 20,034 patients from 24 phase III clinical trials who were on their first treatment for the disease. There was additional patient data in which patients might be on second or third line treatment, having not responded to their initial therapy. Out of these patients, 20,011 were evaluable for analysis of survival time and time until the disease progressed.

"Analysis of this incredibly large population of patients has allowed us to answer meaningful questions, such as the outcomes of young versus older patients. Our results show young age is associated with worse overall survival and progression-free survival," said Lieu. "Young patients with metastatic colorectal cancer represent a group who are at high risk for treatment failure."

Despite the comprehensive nature of the study, more research will be required to identify why colorectal cancer in younger people appears to be more aggressive. Lieu and collaborators from University of Texas MD Anderson Cancer Center are now looking at the biological differences that may ac
'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
303-724-1528
University of Colorado Denver
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New approaches to testing cancer drugs needed -- ESMO press commentary
2. Cancer/Tumor Profiling Market (Personalized Medicine, Biomarker Discovery, Prognosis, Research) Worth $35.03 Billion by 2018 – New Report by MarketsandMarkets
3. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
4. Mesothelioma Awareness Day Sheds Light on Deadly Cancer
5. Diet Doc Hormone Diets & Weight Loss Plans Introduce Hormone Therapy Treatments to Target Belly Fat, the Cause of Many Symptoms of Cancer
6. Chicago Medical Malpractice Lawyers of Salvi, Schostok & Pritchard P.C. Call Attention to Issue of Cancer Misdiagnosis
7. Voices Against Brain Cancer Discusses Recent Finding By Johns Hopkins Researchers Concerning Brain Tumor Treatments
8. Penn Medicine researcher unveils findings on 2 new weapons against thyroid cancer
9. Combining Chinese and Western medicine could lead to new cancer treatments
10. Actos Bladder Cancer Lawsuit: Bernstein Liebhard LLP Comments on Outcome of Nation’s Second Actos Lawsuit Trial
11. Colorectal cancer screening works
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... (PRWEB) August 28, 2014 Coveros, ... today announced that it has partnered with InfoZen ... the performance start date of 2/4/2014 with U.S. ... Homeland Security (DHS) agency that oversees lawful immigration ... Coveros and InfoZen will automate the integration and ...
(Date:8/28/2014)... On September 1st, the National Pediculosis Association ... The goal is to help families and entire communities ... and without exposures to risky pesticides. The NPA ... exposures to pesticides should be limited as much as ... are often trivialized in the media, which present only ...
(Date:8/27/2014)... August 28, 2014 Aeroflow Healthcare ... acquire as part of a strategic expansion of ... positioned for taking ownership of new businesses through ... economies of scale. , Last week, the company ... Hometown Respiratory to increase service in the High ...
(Date:8/27/2014)... The report provides market analysis of ... Range Finder, LIDAR, 3D scanner, Laser Weapon, Dazzlers, Laser ... Laser Altimeter) by Domain (Aerospace, Defense and Homeland Security) ... by MarketsandMarkets, and its application in the aerospace and ... Laser Systems market is expected to register a CAGR ...
(Date:8/27/2014)... August 28, 2014 Recently, BambooIndustry.com, an innovative ... has announced that new bamboo panels are now ... providing deep discounts for clients worldwide. All people that place ... discounted rate, from 10 to 30 percent off. , ... new panels. “At the moment, all our new and old ...
Breaking Medicine News(10 mins):Health News:Coveros Partners with InfoZen on USCIS Transformation Integration Award 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:Aeroflow Healthcare Seeks Strategic Acquisition Opportunities 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2
... , MONDAY, Jan. 16 (HealthDay News) -- Lip ... talk, a new study reports. The finding challenges ... listening to people around them, according to the Florida Atlantic ... ways to diagnose autism spectrum disorders. Videos of women ...
... News) -- Children delivered by Cesarean section appear to be ... 3, a new study says. The findings support the ... than 37,000 participants in the Norwegian Mother and Child Cohort ... were delivered by planned or emergency C-section with those who ...
... (HealthDay News) -- The use of street drugs known as ... warns. It describes the first known case of necrotizing ... So-called bath salts are sold as synthetic powders that "often ... on Drug Abuse, which in February warned that injections might ...
... which is available free online at http://www.shef.ac.uk/FRAX/ , ... the world the online version alone is used to ... annually, with numbers growing steadily. The FRAX ... the input of Bone Mineral Density (BMD) values measured at ...
... a baseball game, the home plate umpire must instantaneously ... strike. In new research from the University of Chicago, ... these kinds of visual categories are encoded. While ... to quickly determine the category of a moving visual ...
... , SUNDAY, Jan. 15 (HealthDay News) -- When ... impulsive, saving less and borrowing more, according to a new ... when females are scarce, males become more competitive. They compete ... assistant professor of marketing at the Carlson School of Management ...
Cached Medicine News:Health News:Is Continued Lip-Reading an Early Sign of Autism? 2Health News:Children Born by C-Section at Slightly Higher Asthma Risk 2Health News:'Bath-Salts' Injection Leads to Flesh-Eating Disease 2Health News:Enormous growth in use of WHO Fracture Risk Assessment Tool 2Health News:Neural balls and strikes: Where categories live in the brain 2Health News:Neural balls and strikes: Where categories live in the brain 3Health News:Do Men Flash Cash to Find a Mate? 2
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... new market research report is available ... Chinese Guidebook for Application and Approval ... Regulations to Practices (2014 Edition) ... Now, Chinese regulations ...
(Date:8/27/2014)... -- CVS Caremark (NYSE: CVS ) announced today ... MedStar Health, a leading health care system with ten ... Washington, DC , region, which will ... patients. Through this clinical affiliation, MedStar Health patients will ... chronic disease monitoring and wellness programs at CVS/pharmacy stores ...
(Date:8/27/2014)... 27, 2014 Amgen (NASDAQ: AMGN ... (FDA) has granted priority review designation for ivabradine for ... an oral drug that inhibits the I ... the body,s cardiac pacemaker. 1 Ivabradine works to ... contractility or ventricular repolarization. 1 Heart failure is ...
Breaking Medicine Technology:Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... 18, 2007 /PRNewswire-FirstCall/ -- Vical,Incorporated today announced that ... following interim analysis of data,from the first 41 ... an,angiogenesis product candidate using Vical's DNA delivery,technology. Based ... the trial had been achieved with statistical,significance and ...
... Primary Endpoint of Improvement in Overall,Survival, WESTMINSTER, ... Inc. today announced top line results from,ENRICH, ... Efaproxyn ,(efaproxiral) plus whole brain radiation therapy ... breast cancer. The study,failed to achieve its ...
Cached Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
... GonoGen™ is a monoclonal ... for the confirmatory identification of ... not require isolated, viable or ... specimen and two minute rotation, ...
Rapid Test Kit...
... a novel device for the growth ... and Neisseria meningitidis. This product ... is easily transportable as a self-contained ... and examine the growth of organisms ...
Medicine Products: